p53 induces NF-κB activation by an IκB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1

被引:221
作者
Bohuslav, J
Chen, LF
Kwon, H
Mu, YJ
Greene, WC
机构
[1] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA
关键词
D O I
10.1074/jbc.M313509200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Apoptosis induced by p53 has been proposed to involve activation of the transcription factor NF-kappaB. Here we describe the novel molecular mechanism through which p53 and DNA-damaging agents activate NF-kappaB. NF-kappaB induction by p53 does not occur through classical activation of the IkappaB kinases and degradation of IkappaBalpha. Rather, p53 expression stimulates the serine/threonine kinase ribosomal S6 kinase 1 (RSK1), which in turn phosphorylates the p65 subunit of NF-kappaB. The lower affinity of RSK1-phosphorylated p65 for its negative regulator, IkappaBalpha, decreases IkappaBalpha-mediated nuclear export of shuttling forms of NF-kappaB, thereby promoting the binding and action of NF-kappaB on cognate kappaB enhancers. These findings highlight a rather unusual pathway of NF-kappaB activation, which is utilized by the p53 tumor suppressor.
引用
收藏
页码:26115 / 26125
页数:11
相关论文
共 81 条
[1]   Absence of mutations in the transforming growth factor-β inducible early gene 1, TIEG1, in pancreatic cancer [J].
Antonello, D ;
Moore, PS ;
Zamboni, G ;
Falconi, M ;
Scarpa, A .
CANCER LETTERS, 2002, 183 (02) :179-183
[2]  
ARENZANASEISDEDOS F, 1995, MOL CELL BIOL, V15, P2689
[3]   Recruitment of p300/CBP in p53-dependent signal pathways [J].
Avantaggiati, ML ;
Ogryzko, V ;
Gardner, K ;
Giordano, A ;
Levine, AS ;
Kelly, K .
CELL, 1997, 89 (07) :1175-1184
[4]   SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53 [J].
BAKER, SJ ;
MARKOWITZ, S ;
FEARON, ER ;
WILLSON, JKV ;
VOGELSTEIN, B .
SCIENCE, 1990, 249 (4971) :912-915
[5]   Role of reactive oxygen intermediates in activation-induced CD95 (APO-1/Fas) ligand expression [J].
Bauer, MKA ;
Vogt, M ;
Los, M ;
Siegel, J ;
Wessellborg, S ;
Schulze-Osthoff, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (14) :8048-8055
[6]   EMBRYONIC LETHALITY AND LIVER DEGENERATION IN MICE LACKING THE RELA COMPONENT OF NF-KAPPA-B [J].
BEG, AA ;
SHA, WC ;
BRONSON, RT ;
GHOSH, S ;
BALTIMORE, D .
NATURE, 1995, 376 (6536) :167-170
[7]   Sequential DNA damage-independent and -dependent activation of NF-κB by UV [J].
Bender, K ;
Göttlicher, M ;
Whiteside, S ;
Rahmsdorf, HJ ;
Herrlich, P .
EMBO JOURNAL, 1998, 17 (17) :5170-5181
[8]   HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I TAX ASSOCIATES WITH AND IS NEGATIVELY REGULATED BY THE NF-KAPPA-B2 P100 GENE-PRODUCT - IMPLICATIONS FOR VIRAL LATENCY [J].
BERAUD, C ;
SUN, SC ;
GANCHI, P ;
BALLARD, DW ;
GREENE, WC .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (02) :1374-1382
[9]   The c-Rel transcription factor can both induce and inhibit apoptosis in the same cells via the upregulation of MnSOD [J].
Bernard, D ;
Monte, D ;
Vandenbunder, B ;
Abbadie, C .
ONCOGENE, 2002, 21 (28) :4392-4402
[10]   PYRROLIDINE DITHIOCARBAMATE, A POTENT INHIBITOR OF NUCLEAR FACTOR KAPPA-B (NF-KAPPA-B) ACTIVATION, PREVENTS APOPTOSIS IN HUMAN PROMYELOCYTIC LEUKEMIA HL-60 CELLS AND THYMOCYTES [J].
BESSHO, R ;
MATSUBARA, K ;
KUBOTA, M ;
KUWAKADO, K ;
HIROTA, H ;
WAKAZONO, Y ;
LIN, YW ;
OKUDA, A ;
KAWAI, M ;
NISHIKOMORI, R ;
HEIKE, T .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (10) :1883-1889